Trifunctional bispecific antibody treatment of ascites due to ovarian cancer: A phase I/II study

R. Kimmig; B. Schmalfeldt; A. Burges; S. Braun; M. Jiger; M. A. Ströhlein; B. Wimberger; M. Kiechle; M. M. Heiss; H. Lindhofer

doi:10.1016/S0959-8049(01)80423-8

Trifunctional bispecific antibody treatment of ascites due to ovarian cancer: A phase I/II study

R. Kimmig
, B. Schmalfeldt
, A. Burges
, S. Braun
, M. Jiger
, M. A. Ströhlein
, B. Wimberger
, M. Kiechle
, M. M. Heiss
, H. Lindhofer

Ludwig-Maximilians-Universität München

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	S59
Journal	European Journal of Cancer
Volume	37
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1016/S0959-8049(01)80423-8
State	Published - 2001
Externally published	Yes

Access to Document

10.1016/S0959-8049(01)80423-8

Cite this

@article{c841cdcf6ab745cf91a5cea248bd688d,

title = "Trifunctional bispecific antibody treatment of ascites due to ovarian cancer: A phase I/II study",

author = "R. Kimmig and B. Schmalfeldt and A. Burges and S. Braun and M. Jiger and Str{\"o}hlein, \{M. A.\} and B. Wimberger and M. Kiechle and Heiss, \{M. M.\} and H. Lindhofer",

year = "2001",

doi = "10.1016/S0959-8049(01)80423-8",

language = "English",

volume = "37",

pages = "S59",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Trifunctional bispecific antibody treatment of ascites due to ovarian cancer

T2 - A phase I/II study

AU - Kimmig, R.

AU - Schmalfeldt, B.

AU - Burges, A.

AU - Braun, S.

AU - Jiger, M.

AU - Ströhlein, M. A.

AU - Wimberger, B.

AU - Kiechle, M.

AU - Heiss, M. M.

AU - Lindhofer, H.

PY - 2001

Y1 - 2001

UR - https://www.scopus.com/pages/publications/33645468424

U2 - 10.1016/S0959-8049(01)80423-8

DO - 10.1016/S0959-8049(01)80423-8

M3 - Article

AN - SCOPUS:33645468424

SN - 0959-8049

VL - 37

SP - S59

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - SUPPL. 1

ER -

Trifunctional bispecific antibody treatment of ascites due to ovarian cancer: A phase I/II study

Access to Document

Other files and links

Cite this